Nasdaq
RNAZ
TransCode Therapeutics, Inc.
- Health Care
- Listed 2021
- 1 day
- +0.5%
- 1 month
- −49.4%
- 1 year
- −61.6%
$4.27 · Mkt cap $4.52M
At the 6 Aug 2026 close
Nasdaq
TransCode Therapeutics, Inc.
$4.27 · Mkt cap $4.52M
At the 6 Aug 2026 close
TransCode Therapeutics, Inc. trades under the ticker RNAZ on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2021. Its market capitalisation is $4.52M. The last closing price was $4.27, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −61.6%, and −49.4% over the past month. Returns are price returns and exclude dividends.
This page exists because RNAZ is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.